119540-36-2

Basic information

• Product Name: 1H-Pyrazole, 3-(bromomethyl)-1-(4-methoxyphenyl)-5-(4-methylphenyl)-
• CAS NO: 119540-36-2
• Molecular Formula: C18H17BrN2O
• Molecular Weight: 357.25
• Mol File: 119540-36-2.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 1H-Pyrazole, 3-(bromomethyl)-1-(4-methoxyphenyl)-5-(4-methylphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrazole, 3-(bromomethyl)-1-(4-methoxyphenyl)-5-(4-methylphenyl)-(119540-36-2)
• EPA Substance Registry System: 1H-Pyrazole, 3-(bromomethyl)-1-(4-methoxyphenyl)-5-(4-methylphenyl)-(119540-36-2)

Safety Data

• Hazardous Substances Data: 119540-36-2(Hazardous Substances Data)

Upstream product

• 3471-32-7 4-Methoxyphenylhydrazine 
• 119540-32-8 ethyl 1-(4-methoxyphenyl)-5-(4-methylphenyl)pyrazole-3-carboxylate 
• 119540-34-0 3-Hydroxymethyl-1-(4-methoxyphenyl)-5-(4-methylphenyl)pyrazole 

Downstream Products

• 119540-42-0 2-(2-Methoxy-phenyl)-3-[1-(4-methoxy-phenyl)-5-p-tolyl-1H-pyrazol-3-yl]-propionic acid ethyl ester 
• 648864-52-2 3-[1-(4-methoxy-phenyl)-5-p-tolyl-1H-pyrazol-3-yl]-2-m-tolyl-propionic acid 
• 648861-60-3 3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionic acid 
• 1000805-24-2 3-[1-(4-methoxy-phenyl)-5-p-tolyl-1H-pyrazol-3-yl]-2-m-tolyl-propionic acid ethyl ester 
• 119540-44-2 2-Biphenyl-4-yl-3-[1-(4-methoxy-phenyl)-5-p-tolyl-1H-pyrazol-3-yl]-propionic acid ethyl ester 
• 119540-43-1 3-[1-(4-Methoxy-phenyl)-5-p-tolyl-1H-pyrazol-3-yl]-2-pyridin-2-yl-propionic acid ethyl ester 
• 119577-24-1 3-[1-(4-Methoxy-phenyl)-5-p-tolyl-1H-pyrazol-3-yl]-2-naphthalen-1-yl-propionic acid ethyl ester 
• 648863-04-1 3-[1-(4-methoxy-phenyl)-5-p-tolyl-1H-pyrazol-3-yl]-2-m-tolyl-propionitrile 

Relevant articles and documents

SAR studies of 1,5-diarylpyrazole-based CCK1 receptor antagonists

A high throughput screening campaign revealed compound 1 as a potent antagonist of the human CCK1 receptor. Here, we report the syntheses and SAR studies of 1,5-diarylpyrazole analogs with various structural modifications of the alkane side cha

Pyrazole CCK1 receptor antagonists. Part 1: Solution-phase library synthesis and determination of Free-Wilson additivity

High throughput screening revealed compound 1 as a potent antagonist of the CCK1 receptor. Evaluation of the CCK1 SAR in a series of these diarylpyrazole antagonists was conducted in a matrix synthesis format revealing additive (Free

CCK-1 RECEPTOR MODULATORS

There are provided by the present invention certain pyrazole based CCK-1 receptor modulators.